Gene study in leukemia patients reveals key mutation patterns

NCT ID NCT07004816

First seen Nov 18, 2025 · Last updated May 19, 2026 · Updated 22 times

Summary

This study aimed to find how often IDH1/2 gene mutations occur in adults with acute myeloid leukemia (AML) in China and how these mutations affect patient outcomes. Researchers analyzed stored leukemia samples from over 1,000 patients. The study was terminated early, but the data collected helps scientists better understand the role of these mutations in AML.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AML are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Institute of Hematology & Blood Diseases Hospital

    Tianjin, Tianjin Municipality, China

Conditions

Explore the condition pages connected to this study.